ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,604,000 | -6.8% | 6,500,000 | 0.0% | 0.20% | -15.3% |
| Q4 2020 | $7,085,000 | +31.9% | 6,500,000 | +25.0% | 0.24% | +9.3% |
| Q3 2020 | $5,373,000 | -2.3% | 5,200,000 | +4.0% | 0.22% | -13.3% |
| Q2 2020 | $5,499,000 | +18.5% | 5,000,000 | +9.9% | 0.25% | +5.5% |
| Q1 2020 | $4,642,000 | -7.8% | 4,550,000 | +3.4% | 0.24% | +15.7% |
| Q4 2019 | $5,037,000 | +0.5% | 4,400,000 | 0.0% | 0.20% | -4.2% |
| Q3 2019 | $5,014,000 | -33.1% | 4,400,000 | -37.1% | 0.21% | -58.2% |
| Q4 2015 | $7,495,000 | – | 7,000,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 7,000,000 | $6,536,000 | 3.36% |
| Sonora Investment Management, LLC | 15,550,000 | $14,486,691,000 | 3.04% |
| Jabre Capital Partners S.A. | 7,550,000 | $7,050,000 | 0.96% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,972,000 | $66,281,000 | 0.96% |
| MACKAY SHIELDS LLC | 10,243,000 | $9,558,000 | 0.43% |
| ARISTEIA CAPITAL, L.L.C. | 7,500,000 | $6,998,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,100,000 | $25,384,000 | 0.33% |
| SSI INVESTMENT MANAGEMENT LLC | 2,671,000 | $2,485,000 | 0.22% |
| Verition Fund Management LLC | 2,000,000 | $1,866,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,849,000 | $5,453,000 | 0.19% |